Amnion Life on Self Managed 2019

Amnion Life is elevating funds independently by way of Reg D 506(c) increase. The corporate has developed a synthetic womb for preterm infants to copy the fluid surroundings of the mom’s womb. The system, AmnioBed Golden Hour, makes use of artificial amniotic fluid to forestall conventional hypothermia in preterm infants and reduces different associated issues. Amnion Life has two issued patents within the US and China, whereas the patents are pending in Europe, Japan, India, and Australia. Amir Fassihi based Amnion Life in 2016. The present crowdfunding marketing campaign has a most goal of $2.5 million. The marketing campaign proceeds can be used for development and growth.